Aerie Pharmaceuticals (AERI) stock forecast for 2023. Forecast tables and graphs.

Aerie Pharmaceuticals (AERI) stock forecast for 2023

Last update: 08-15-2022, 14:01

Sector: Healthcare

The share price of Aerie Pharmaceuticals, Inc. (AERI) now

What analysts predict:: $18.78

52-week high/low: $17.21 / $4.81

50/200 Day Moving Average: $7.67 / $8.1

This figure corresponds to the average price over the previous 50/200 days. For Aerie Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Aerie Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Aerie Pharmaceuticals stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aerie Pharmaceuticals stock price in 2023. How much will one Aerie Pharmaceuticals share be worth in 2023?

Is it worth taking profit / loss on Aerie Pharmaceuticals stock now or waiting? What are analysts' forecasts for Aerie Pharmaceuticals stock?

We forecast Aerie Pharmaceuticals stock performance using neural networks based on historical data on Aerie Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

The Aerie Pharmaceuticals stock prediction results are shown below and presented as a graph, table and text information.

Aerie Pharmaceuticals stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Aerie Pharmaceuticals analysts is $18.78.

Today 200 Day Moving Average is the support level (8.1 $).

50 Day Moving Average is the support level (7.67 $).




Historical and forecast chart of Aerie Pharmaceuticals stock

The chart below shows the historical price of Aerie Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aerie Pharmaceuticals stock price can be found in the table below.

Aerie Pharmaceuticals (AERI) Forecast for 2023

Month Target Pes. Opt. Vol., %
Jan 11.22 9.56 12.68 24.60 %
Feb 13.47 12.15 14.57 16.64 %
Mar 15.57 14.64 16.60 11.82 %
Apr 15.26 13.43 15.90 15.55 %
May 15.14 12.99 16.50 21.28 %
Jun 15.41 13.28 16.02 17.12 %
Jul 16.43 13.80 17.21 19.85 %
Aug 13.37 12.73 14.55 12.50 %
Sep 15.40 13.25 17.81 25.61 %
Oct 15.09 12.74 16.42 22.43 %
Nov 18.08 16.60 19.28 13.88 %
Dec 20.14 18.94 21.84 13.28 %

Aerie Pharmaceuticals information and performance

Aerie Pharmaceuticals Inc. (Nasdaq: AERI) is a publicly traded, clinical stage pharmaceutical company dedicated to discovering, developing and commercializing first-class treatments for patients with glaucoma and other eye conditions.

Aerie Pharmaceuticals Address

4301 EMPEROR BOULEVARD, SUITE 400, DURHAM, NC, US

Market Capitalization: 571 094 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -5 987 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.472

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.225

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.512

Enterprise Value (EV) /Revenue

EV To EBITDA: -182.78

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 49359900

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Aerie Pharmaceuticals price target for 2021 by month


Target values for the price of one Aerie Pharmaceuticals share for Jan 2023.

The weighted average target price per Aerie Pharmaceuticals share in Jan 2023 is: 11.22. In Jan, the negative dynamics for Momo shares will prevail with possible monthly volatility of 24.602% volatility is expected.

Pessimistic target level: 9.56

Optimistic target level: 12.68


Target values for the price of one Aerie Pharmaceuticals share for Feb 2023.

The weighted average target price per Aerie Pharmaceuticals share in Feb 2023 is: 13.47. In Feb, the positive dynamics for Momo shares will prevail with possible monthly volatility of 16.635% volatility is expected.

Pessimistic target level: 12.15

Optimistic target level: 14.57


Target values for the price of one Aerie Pharmaceuticals share for Mar 2023.

The weighted average target price per Aerie Pharmaceuticals share in Mar 2023 is: 15.57. In Mar, the positive dynamics for Momo shares will prevail with possible monthly volatility of 11.820% volatility is expected.

Pessimistic target level: 14.64

Optimistic target level: 16.60


Target values for the price of one Aerie Pharmaceuticals share for Apr 2023.

The weighted average target price per Aerie Pharmaceuticals share in Apr 2023 is: 15.26. In Apr, the negative dynamics for Momo shares will prevail with possible monthly volatility of 15.547% volatility is expected.

Pessimistic target level: 13.43

Optimistic target level: 15.90


Target values for the price of one Aerie Pharmaceuticals share for May 2023.

The weighted average target price per Aerie Pharmaceuticals share in May 2023 is: 15.14. In May, the negative dynamics for Momo shares will prevail with possible monthly volatility of 21.284% volatility is expected.

Pessimistic target level: 12.99

Optimistic target level: 16.50


Target values for the price of one Aerie Pharmaceuticals share for Jun 2023.

The weighted average target price per Aerie Pharmaceuticals share in Jun 2023 is: 15.41. In Jun, the positive dynamics for Momo shares will prevail with possible monthly volatility of 17.115% volatility is expected.

Pessimistic target level: 13.28

Optimistic target level: 16.02


Target values for the price of one Aerie Pharmaceuticals share for Jul 2023.

The weighted average target price per Aerie Pharmaceuticals share in Jul 2023 is: 16.43. In Jul, the positive dynamics for Momo shares will prevail with possible monthly volatility of 19.847% volatility is expected.

Pessimistic target level: 13.80

Optimistic target level: 17.21


Target values for the price of one Aerie Pharmaceuticals share for Aug 2023.

The weighted average target price per Aerie Pharmaceuticals share in Aug 2023 is: 13.37. In Aug, the negative dynamics for Momo shares will prevail with possible monthly volatility of 12.500% volatility is expected.

Pessimistic target level: 12.73

Optimistic target level: 14.55


Target values for the price of one Aerie Pharmaceuticals share for Sep 2023.

The weighted average target price per Aerie Pharmaceuticals share in Sep 2023 is: 15.40. In Sep, the positive dynamics for Momo shares will prevail with possible monthly volatility of 25.606% volatility is expected.

Pessimistic target level: 13.25

Optimistic target level: 17.81


Target values for the price of one Aerie Pharmaceuticals share for Oct 2023.

The weighted average target price per Aerie Pharmaceuticals share in Oct 2023 is: 15.09. In Oct, the negative dynamics for Momo shares will prevail with possible monthly volatility of 22.426% volatility is expected.

Pessimistic target level: 12.74

Optimistic target level: 16.42


Target values for the price of one Aerie Pharmaceuticals share for Nov 2023.

The weighted average target price per Aerie Pharmaceuticals share in Nov 2023 is: 18.08. In Nov, the positive dynamics for Momo shares will prevail with possible monthly volatility of 13.884% volatility is expected.

Pessimistic target level: 16.60

Optimistic target level: 19.28


Target values for the price of one Aerie Pharmaceuticals share for Dec 2023.

The weighted average target price per Aerie Pharmaceuticals share in Dec 2023 is: 20.14. In Dec, the positive dynamics for Momo shares will prevail with possible monthly volatility of 13.284% volatility is expected.

Pessimistic target level: 18.94

Optimistic target level: 21.84




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.